Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
View Older Stories View More Recent Stories
-
ACI Worldwide Present at Multiple Investor Conferences
-
TransMedics Group (TMDX) Prices Upsized 3.25M Share Offering at $40/sh
-
Form 8.3 - [Biffa plc - 04 08 2022] - (CGWL)
-
TransMedics Announces Upsize and Pricing of Public Offering of Common Stock
-
CANACCORD GENUITY GROUP INC. REPORTS FIRST QUARTER FISCAL 2023 RESULTS
-
Standard Lithium to Participate in Canaccord Genuity 42nd Annual Growth Conference
-
Olema Oncology to Present at Canaccord Genuity 42nd Annual Growth Conference
-
Olema Oncology to Present at Canaccord Genuity 42nd Annual Growth Conference
-
Vapotherm to Participate in the Canaccord Genuity 42nd Annual Growth Conference
-
EverCommerce to Present at August Investor Conferences
-
EverCommerce to Present at August Investor Conferences
-
MIMEDX to Present at the Canaccord Genuity 42nd Annual Growth Conference
-
KORU Medical Systems to Participate in Canaccord Genuity's 42nd Annual Growth Conference
-
Calyxt Reports Second Quarter 2022 Financial Results and Provides Corporate Update
-
Voyager Therapeutics Prioritizes Pipeline and Reports Second Quarter 2022 Financial and Operating Results
-
Trupanion Announces Upcoming Investor Conference Participation
-
PLBY Group to Participate in The Canaccord Genuity 42nd Annual Growth Conference
-
ARHT Media to Participate at Canaccord Genuity’s 42nd Annual Growth Conference
-
Form 8.3 - [EMIS Group plc - 03 08 2022] - (CGWL)
-
Ameresco to Participate at Upcoming Conferences
-
Apnimed to Participate in the 42nd Annual Canaccord Genuity Global Growth Conference
-
Quince Therapeutics to Present at Canaccord Genuity 42nd Annual Growth Conference on August 11, 2022
-
NAPCO Security Technologies To Present at the 42nd Annual Canaccord Genuity Growth Conference
-
Knight to Present at the Canaccord Genuity 42nd Annual Growth Conference
-
Propel to Participate in Canaccord Growth Conference
-
Walden Biosciences Announces Presentation at Canaccord Genuity 42nd Annual Growth Conference
-
Vaxxinity to Present at the Canaccord Genuity 42nd Annual Growth Conference
-
KnowBe4 Announces Second Quarter 2022 Financial Results
-
KnowBe4 Announces Second Quarter 2022 Financial Results
-
Vaxxinity to Present at the Canaccord Genuity 42nd Annual Growth Conference
-
Seres Therapeutics to Present at Canaccord Genuity 42nd Annual Growth Conference
-
NanoString to Webcast Presentations from Two Upcoming Healthcare Conferences
-
TransMedics Group (TMDX) Announces Proposed $100M Stock Offering
-
TransMedics Announces Proposed Public Offering of Common Stock
-
Quanterix to Participate in the Canaccord Genuity 42nd Annual Growth Conference
-
AdTheorent to Present at the Canaccord Genuity 42nd Annual Growth Conference
-
AdTheorent to Present at the Canaccord Genuity 42nd Annual Growth Conference
-
Dexcom Announces Upcoming Conference Presentation
-
Impinj to Participate in Upcoming Investor Conferences
-
AppHarvest announces Q2 2022 results showing continued improvements in core operations, progress to quadruple farm network and securing nondilutive expansion capital
-
Avalara to Present at Upcoming Investor Conferences
-
AppHarvest announces Q2 2022 results showing continued improvements in core operations, progress to quadruple farm network and securing nondilutive expansion capital
-
Definitive Healthcare to Present at the Canaccord Genuity 42nd Annual Growth Conference
-
Clover Health to Present at Canaccord Genuity 42nd Annual Growth Conference on August 10, 2022
-
BigCommerce to Present at Upcoming Investor Conferences
-
Definitive Healthcare to Present at the Canaccord Genuity 42nd Annual Growth Conference
-
Bandwidth Announces Second Quarter 2022 Financial Results Exceeding Guidance
-
AngioDynamics to Present at the Canaccord Genuity Growth Conference
-
Atara Biotherapeutics to Present at the Canaccord Genuity 42nd Annual Growth Conference
-
ATEX Announces Upsize of Previously Announced Private Placement Financing to up to $10.8 Million

